ACTOS (pioglitazone HCl) Reduces Risk In Treating Diabetes
Today were presented the new findings in a late-breaker session at the World Congress of Cardiology in Barcelona. An oral antidiabetic medication ACTOS (pioglitazone HCl) was investigated and it was revealed that Actos drug significantly reduced the risk of recurrent stroke in high-risk patients with type 2 diabetes. Nowadays patients with diabetes are at an [...]
Read User's Comments